Anti-LINGO-1 trial results

A phase 2 study involving 82 people found that repair of myelin on the optic nerve was better in people taking a drug called anti-LINGO-1 than in a group taking a placebo. Further trials are planned. Biogen press release Daily Telegraph Forbes Latest MS research update
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news